The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by providing critical resources, staff and facilities support for the Regional Biocontainment Laboratories (RBLs). The RBLs provide biosafety level 2 and 3 (BSL-2/3) biocontainment facilities for research on infectious diseases. They play a critical role in public health emergency response by facilitating key activities related to infectious disease outbreaks and biosafety/biosecurity concerns. Congress has denoted the RBLs a NIAID research priority. This program will provide multi-year funding for facility maintenance, operations and biocontainment-specific training for personnel to maintain a capable BSL-3 level workforce in the United States. This is a Forecast for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see the Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

Education

• Public and state institutions of higher education
• Private institutions of higher education